Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accendra HealthACH -10.00%53 3-Year EBITDA Growth Rate is -16.10% as of Jun. 2026. GuruFocus rates ACH with a GF Score™ of 53/100 and a GF Value™ of $5.53 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 105 Medical Distribution companies, Accendra Health ranks worse than 87.62% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was -16.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Accendra Health was 30.10% per year. The lowest was -16.10% per year. And the median was 5.75% per year.
Accendra Health (NYSE:ACH) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Accendra Health 3-Year EBITDA Growth Rate Related Terms
ACH vs FOCL, YI, COSM: 3-Year EBITDA Growth Rate Comparison
For the Medical Distribution subindustry, Accendra Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health 3-Year EBITDA Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Accendra Health's 3-Year EBITDA Growth Rate falls into.
Accendra Health 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -16.10% mean?
Accendra Health (ACH) has a 3-Year EBITDA Growth Rate of -16.10% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #92 out of 105 companies in the Medical Distribution industry, placing it in the top 87.6%.
Is Accendra Health's 3-Year EBITDA Growth Rate too high?
Accendra Health's current 3-Year EBITDA Growth Rate is -16.10%. Based on the distribution chart, Accendra Health ranks #92 out of 105 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's 3-Year EBITDA Growth Rate compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #92 out of 105 companies for 3-Year EBITDA Growth Rate. This places Accendra Health in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 5.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Distribution company?
The median 3-Year EBITDA Growth Rate among Medical Distribution companies is 5.40, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Accendra Health and its competitors. For the Medical Distribution industry, the median 3-Year EBITDA Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current 3-Year EBITDA Growth Rate is -16.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.53, compared to a current price of $1.26 — trading 77.2% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -16.10%. Accendra Health's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Accendra Health (ACH), the current 3-Year EBITDA Growth Rate is -16.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $1.26 is trading 77.2% below its estimated GF Value™ of $5.53.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
3-Year EBITDA Growth Rate: -16.10%
GF Value™: $5.53 vs. price of $1.26 (77.2% below fair value)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
53GF Score
Get the complete analysis for ACH
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
